Keywords: Hikma Pharma, Injectables business, Unsolicited interest, Valuations, Share price, Panmure Gordon

Hikma leaps as it confirms unsolicited interest in Injectables business

Article | 04 March 2013

Print This

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) saw its shares jump 8.1% to£9.365 on Friday, after the company confirmed that it ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in